- IBDEI256 ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,34208,1,3,0)
- ;;=3^Neuroleptic-Induced Parkinsonism
- ;;^UTILITY(U,$J,358.3,34208,1,4,0)
- ;;=4^G21.11
- ;;^UTILITY(U,$J,358.3,34208,2)
- ;;=^5003772
- ;;^UTILITY(U,$J,358.3,34209,0)
- ;;=G24.01^^134^1731^15
- ;;^UTILITY(U,$J,358.3,34209,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34209,1,3,0)
- ;;=3^Tardive Dyskinesia
- ;;^UTILITY(U,$J,358.3,34209,1,4,0)
- ;;=4^G24.01
- ;;^UTILITY(U,$J,358.3,34209,2)
- ;;=^5003784
- ;;^UTILITY(U,$J,358.3,34210,0)
- ;;=G24.09^^134^1731^16
- ;;^UTILITY(U,$J,358.3,34210,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34210,1,3,0)
- ;;=3^Tardive Dystonia
- ;;^UTILITY(U,$J,358.3,34210,1,4,0)
- ;;=4^G24.09
- ;;^UTILITY(U,$J,358.3,34210,2)
- ;;=^5003786
- ;;^UTILITY(U,$J,358.3,34211,0)
- ;;=G25.1^^134^1731^11
- ;;^UTILITY(U,$J,358.3,34211,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34211,1,3,0)
- ;;=3^Medication-Induced Postural Tremor
- ;;^UTILITY(U,$J,358.3,34211,1,4,0)
- ;;=4^G25.1
- ;;^UTILITY(U,$J,358.3,34211,2)
- ;;=^5003792
- ;;^UTILITY(U,$J,358.3,34212,0)
- ;;=G25.71^^134^1731^14
- ;;^UTILITY(U,$J,358.3,34212,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34212,1,3,0)
- ;;=3^Tardive Akathisia
- ;;^UTILITY(U,$J,358.3,34212,1,4,0)
- ;;=4^G25.71
- ;;^UTILITY(U,$J,358.3,34212,2)
- ;;=^5003799
- ;;^UTILITY(U,$J,358.3,34213,0)
- ;;=G25.79^^134^1731^9
- ;;^UTILITY(U,$J,358.3,34213,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34213,1,3,0)
- ;;=3^Medication-Induced Movement Disorder,Other
- ;;^UTILITY(U,$J,358.3,34213,1,4,0)
- ;;=4^G25.79
- ;;^UTILITY(U,$J,358.3,34213,2)
- ;;=^5003800
- ;;^UTILITY(U,$J,358.3,34214,0)
- ;;=T43.205A^^134^1731^4
- ;;^UTILITY(U,$J,358.3,34214,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34214,1,3,0)
- ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
- ;;^UTILITY(U,$J,358.3,34214,1,4,0)
- ;;=4^T43.205A
- ;;^UTILITY(U,$J,358.3,34214,2)
- ;;=^5050540
- ;;^UTILITY(U,$J,358.3,34215,0)
- ;;=T43.205D^^134^1731^5
- ;;^UTILITY(U,$J,358.3,34215,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34215,1,3,0)
- ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
- ;;^UTILITY(U,$J,358.3,34215,1,4,0)
- ;;=4^T43.205D
- ;;^UTILITY(U,$J,358.3,34215,2)
- ;;=^5050541
- ;;^UTILITY(U,$J,358.3,34216,0)
- ;;=T43.205S^^134^1731^6
- ;;^UTILITY(U,$J,358.3,34216,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34216,1,3,0)
- ;;=3^Antidepressant Discontinuation Syndrome,Sequela
- ;;^UTILITY(U,$J,358.3,34216,1,4,0)
- ;;=4^T43.205S
- ;;^UTILITY(U,$J,358.3,34216,2)
- ;;=^5050542
- ;;^UTILITY(U,$J,358.3,34217,0)
- ;;=G25.71^^134^1731^7
- ;;^UTILITY(U,$J,358.3,34217,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34217,1,3,0)
- ;;=3^Medication-Induced Acute Akathisia
- ;;^UTILITY(U,$J,358.3,34217,1,4,0)
- ;;=4^G25.71
- ;;^UTILITY(U,$J,358.3,34217,2)
- ;;=^5003799
- ;;^UTILITY(U,$J,358.3,34218,0)
- ;;=G24.02^^134^1731^8
- ;;^UTILITY(U,$J,358.3,34218,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34218,1,3,0)
- ;;=3^Medication-Induced Acute Dystonia
- ;;^UTILITY(U,$J,358.3,34218,1,4,0)
- ;;=4^G24.02
- ;;^UTILITY(U,$J,358.3,34218,2)
- ;;=^5003785
- ;;^UTILITY(U,$J,358.3,34219,0)
- ;;=G21.0^^134^1731^12
- ;;^UTILITY(U,$J,358.3,34219,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34219,1,3,0)
- ;;=3^Neuroleptic Malignant Syndrome
- ;;^UTILITY(U,$J,358.3,34219,1,4,0)
- ;;=4^G21.0
- ;;^UTILITY(U,$J,358.3,34219,2)
- ;;=^5003771
- ;;^UTILITY(U,$J,358.3,34220,0)
- ;;=T50.905A^^134^1731^1
- ;;^UTILITY(U,$J,358.3,34220,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,34220,1,3,0)
- ;;=3^Adverse Effect of Medication,Other,Init Encntr
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI256 3817 printed Mar 13, 2025@21:26:49 Page 2
- IBDEI256 ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,34208,1,3,0)
- +2 ;;=3^Neuroleptic-Induced Parkinsonism
- +3 ;;^UTILITY(U,$J,358.3,34208,1,4,0)
- +4 ;;=4^G21.11
- +5 ;;^UTILITY(U,$J,358.3,34208,2)
- +6 ;;=^5003772
- +7 ;;^UTILITY(U,$J,358.3,34209,0)
- +8 ;;=G24.01^^134^1731^15
- +9 ;;^UTILITY(U,$J,358.3,34209,1,0)
- +10 ;;=^358.31IA^4^2
- +11 ;;^UTILITY(U,$J,358.3,34209,1,3,0)
- +12 ;;=3^Tardive Dyskinesia
- +13 ;;^UTILITY(U,$J,358.3,34209,1,4,0)
- +14 ;;=4^G24.01
- +15 ;;^UTILITY(U,$J,358.3,34209,2)
- +16 ;;=^5003784
- +17 ;;^UTILITY(U,$J,358.3,34210,0)
- +18 ;;=G24.09^^134^1731^16
- +19 ;;^UTILITY(U,$J,358.3,34210,1,0)
- +20 ;;=^358.31IA^4^2
- +21 ;;^UTILITY(U,$J,358.3,34210,1,3,0)
- +22 ;;=3^Tardive Dystonia
- +23 ;;^UTILITY(U,$J,358.3,34210,1,4,0)
- +24 ;;=4^G24.09
- +25 ;;^UTILITY(U,$J,358.3,34210,2)
- +26 ;;=^5003786
- +27 ;;^UTILITY(U,$J,358.3,34211,0)
- +28 ;;=G25.1^^134^1731^11
- +29 ;;^UTILITY(U,$J,358.3,34211,1,0)
- +30 ;;=^358.31IA^4^2
- +31 ;;^UTILITY(U,$J,358.3,34211,1,3,0)
- +32 ;;=3^Medication-Induced Postural Tremor
- +33 ;;^UTILITY(U,$J,358.3,34211,1,4,0)
- +34 ;;=4^G25.1
- +35 ;;^UTILITY(U,$J,358.3,34211,2)
- +36 ;;=^5003792
- +37 ;;^UTILITY(U,$J,358.3,34212,0)
- +38 ;;=G25.71^^134^1731^14
- +39 ;;^UTILITY(U,$J,358.3,34212,1,0)
- +40 ;;=^358.31IA^4^2
- +41 ;;^UTILITY(U,$J,358.3,34212,1,3,0)
- +42 ;;=3^Tardive Akathisia
- +43 ;;^UTILITY(U,$J,358.3,34212,1,4,0)
- +44 ;;=4^G25.71
- +45 ;;^UTILITY(U,$J,358.3,34212,2)
- +46 ;;=^5003799
- +47 ;;^UTILITY(U,$J,358.3,34213,0)
- +48 ;;=G25.79^^134^1731^9
- +49 ;;^UTILITY(U,$J,358.3,34213,1,0)
- +50 ;;=^358.31IA^4^2
- +51 ;;^UTILITY(U,$J,358.3,34213,1,3,0)
- +52 ;;=3^Medication-Induced Movement Disorder,Other
- +53 ;;^UTILITY(U,$J,358.3,34213,1,4,0)
- +54 ;;=4^G25.79
- +55 ;;^UTILITY(U,$J,358.3,34213,2)
- +56 ;;=^5003800
- +57 ;;^UTILITY(U,$J,358.3,34214,0)
- +58 ;;=T43.205A^^134^1731^4
- +59 ;;^UTILITY(U,$J,358.3,34214,1,0)
- +60 ;;=^358.31IA^4^2
- +61 ;;^UTILITY(U,$J,358.3,34214,1,3,0)
- +62 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
- +63 ;;^UTILITY(U,$J,358.3,34214,1,4,0)
- +64 ;;=4^T43.205A
- +65 ;;^UTILITY(U,$J,358.3,34214,2)
- +66 ;;=^5050540
- +67 ;;^UTILITY(U,$J,358.3,34215,0)
- +68 ;;=T43.205D^^134^1731^5
- +69 ;;^UTILITY(U,$J,358.3,34215,1,0)
- +70 ;;=^358.31IA^4^2
- +71 ;;^UTILITY(U,$J,358.3,34215,1,3,0)
- +72 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
- +73 ;;^UTILITY(U,$J,358.3,34215,1,4,0)
- +74 ;;=4^T43.205D
- +75 ;;^UTILITY(U,$J,358.3,34215,2)
- +76 ;;=^5050541
- +77 ;;^UTILITY(U,$J,358.3,34216,0)
- +78 ;;=T43.205S^^134^1731^6
- +79 ;;^UTILITY(U,$J,358.3,34216,1,0)
- +80 ;;=^358.31IA^4^2
- +81 ;;^UTILITY(U,$J,358.3,34216,1,3,0)
- +82 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
- +83 ;;^UTILITY(U,$J,358.3,34216,1,4,0)
- +84 ;;=4^T43.205S
- +85 ;;^UTILITY(U,$J,358.3,34216,2)
- +86 ;;=^5050542
- +87 ;;^UTILITY(U,$J,358.3,34217,0)
- +88 ;;=G25.71^^134^1731^7
- +89 ;;^UTILITY(U,$J,358.3,34217,1,0)
- +90 ;;=^358.31IA^4^2
- +91 ;;^UTILITY(U,$J,358.3,34217,1,3,0)
- +92 ;;=3^Medication-Induced Acute Akathisia
- +93 ;;^UTILITY(U,$J,358.3,34217,1,4,0)
- +94 ;;=4^G25.71
- +95 ;;^UTILITY(U,$J,358.3,34217,2)
- +96 ;;=^5003799
- +97 ;;^UTILITY(U,$J,358.3,34218,0)
- +98 ;;=G24.02^^134^1731^8
- +99 ;;^UTILITY(U,$J,358.3,34218,1,0)
- +100 ;;=^358.31IA^4^2
- +101 ;;^UTILITY(U,$J,358.3,34218,1,3,0)
- +102 ;;=3^Medication-Induced Acute Dystonia
- +103 ;;^UTILITY(U,$J,358.3,34218,1,4,0)
- +104 ;;=4^G24.02
- +105 ;;^UTILITY(U,$J,358.3,34218,2)
- +106 ;;=^5003785
- +107 ;;^UTILITY(U,$J,358.3,34219,0)
- +108 ;;=G21.0^^134^1731^12
- +109 ;;^UTILITY(U,$J,358.3,34219,1,0)
- +110 ;;=^358.31IA^4^2
- +111 ;;^UTILITY(U,$J,358.3,34219,1,3,0)
- +112 ;;=3^Neuroleptic Malignant Syndrome
- +113 ;;^UTILITY(U,$J,358.3,34219,1,4,0)
- +114 ;;=4^G21.0
- +115 ;;^UTILITY(U,$J,358.3,34219,2)
- +116 ;;=^5003771
- +117 ;;^UTILITY(U,$J,358.3,34220,0)
- +118 ;;=T50.905A^^134^1731^1
- +119 ;;^UTILITY(U,$J,358.3,34220,1,0)
- +120 ;;=^358.31IA^4^2
- +121 ;;^UTILITY(U,$J,358.3,34220,1,3,0)
- +122 ;;=3^Adverse Effect of Medication,Other,Init Encntr
